PEP Flute-selfcare in COVID-19 (PEP-CoV)
COVID-19, SARS-CoV-2
About this trial
This is an interventional prevention trial for COVID-19 focused on measuring COVID-19, SARS-CoV-2, Respiratory symptoms, Positive expiratory pressure, Positive expiratory pressure flute, Airway clearance techniques
Eligibility Criteria
Inclusion Criteria:
- Positive SARS-CoV-2
- Symptoms of SARS-CoV-2 infection e.g. fever, cough and shortness of breath.
- Access to use a smartphone
- Can reply to a questionnaire (sent on email, text messages or via telephone interview) in Danish
- Given informed consent
Exclusion Criteria:
- Age < 18 years.
- Any condition or impairment that, in the opinion of the investigator, makes a potential participant unsuitable for participation or which obstruct participation, such as psychiatric disorders.
- Hospitalised patients or citizens living in nursing homes
Sites / Locations
- Research Unit for Dietary Studies at the Parker Institute, Bispebjerg and Frederiksberg Hospitals
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Treatment group
Control group
The participants will be handed three airway resistances equivalent to a resistance of 10-20 cm H2O alongside one PEP flute. Two videos will guide the participants in use of the PEP flute; one with instructions of the rationale and how to use the flute, including how to choose the suitable resistance and one video, which gives instructions of hygienic maintenance. Participants in the intervention group will be advised to continue use of their PEP flute in the active intervention period of 30 days or at least if they still have respiratory symptoms. They will receive daily text-messages to prompt their reporting and to use the PEP flute according to instructions.
The participants in the control group will receive daily text-messages to prompt their reporting of CAT-scores. To avoid attrition of the trial due to early recovery of symptoms, the project manager will call the participants by phone at day 15 to ask them about their present condition (i.e. CAT-score) and address potential concerns of continued participation of the trial. Otherwise, they will only receive usual care.